Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Colleen R. Maier"'
Autor:
Phillip A. Dennis, Stephen D. Fox, Shigeru Kawabata, Colleen R. Maier, Jose R. Mercado, Regan M. Memmott
Activation of the mammalian target of rapamycin (mTOR) pathway is an important and early event in tobacco carcinogen–induced lung tumorigenesis, and therapies that target mTOR could be effective in the prevention or treatment of lung cancer. The bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752d6f71ad6de8279318b24f69778677
https://doi.org/10.1158/1940-6207.c.6544863.v1
https://doi.org/10.1158/1940-6207.c.6544863.v1
Autor:
Phillip A. Dennis, Stephen D. Fox, Shigeru Kawabata, Colleen R. Maier, Jose R. Mercado, Regan M. Memmott
Related Articles / Press Coverage from Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::653b09bb53e98c27e96058546d53340d
https://doi.org/10.1158/1940-6207.22525698.v1
https://doi.org/10.1158/1940-6207.22525698.v1
Autor:
Phillip A. Dennis, R. Ilona Linnoila, Irem Dogan, Evthokia A. Hobbs, M. Christine Hollander, Colleen R. Maier
Perspectives on This Article from Nicotine Does Not Enhance Tumorigenesis in Mutant K-Ras–Driven Mouse Models of Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30530914627a4224a7a56cbe7b7c7973
https://doi.org/10.1158/1940-6207.22524186.v1
https://doi.org/10.1158/1940-6207.22524186.v1
Autor:
Phillip A. Dennis, Stephen D. Fox, Shigeru Kawabata, Colleen R. Maier, Jose R. Mercado, Regan M. Memmott
Supplementary Figures 1 and 2 from Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abe0f2ec8859db3f6df779832df97c8
https://doi.org/10.1158/1940-6207.22525695
https://doi.org/10.1158/1940-6207.22525695
Autor:
M. Christine Hollander, Phillip A. Dennis, R. Ilona Linnoila, Irem Dogan, Evthokia Hobbs, Colleen R. Maier
Publikováno v:
Cancer Prevention Research. 4:1743-1751
Smoking is the leading cause of preventable cancer deaths in the United States. Nicotine replacement therapies (NRT) have been developed to aid in smoking cessation, which decreases lung cancer incidence. However, the safety of NRT is controversial b
Autor:
Andrew D. Patterson, Colleen R. Maier, Xinxin Ding, M. Christine Hollander, Phillip A. Dennis, Xin Zhou
Publikováno v:
Carcinogenesis. 32:1279-1284
Lung tumors from smokers as well as lung tumors from mice exposed to tobacco carcinogens such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), often carry mutations in K-ras, which activates downstream-signaling pathways such as PI3K/AKT/mTOR
Autor:
Shigeru Kawabata, Jose Mercado, Stephen D. Fox, Colleen R. Maier, Phillip A. Dennis, Regan M. Memmott
Publikováno v:
Cancer prevention research (Philadelphia, Pa.). 3(9)
Activation of the mammalian target of rapamycin (mTOR) pathway is an important and early event in tobacco carcinogen–induced lung tumorigenesis, and therapies that target mTOR could be effective in the prevention or treatment of lung cancer. The bi
Publikováno v:
Cancer Research. 71:1336-1336
Nicotine replacement therapy (NRT) is a popular and effective regimen for the cessation of smoking. Expanded use of NRT is controversial based on preclinical studies that show that nicotine activates signaling pathways that promote cellular survival
Autor:
Colleen R. Maier, Matthew Dallos, Shigeru Kawabata, Regan M. Memmott, Ajaikumar B. Kunnumakkara, Brendan J. Quinn, Joell J. Gills, Phillip A. Dennis, Christine M. Hollander
Publikováno v:
Cancer Research. 71:614-614
Li-Fraumeni Syndrome (LFS) is a rare autosomal hereditary disorder that is commonly associated with germline mutations in the TP53 gene. People with LFS are at high risk to develop a wide range of malignancies including breast cancer, brain tumors, a